Genome-wide association studies of autoimmune vitiligo identify 23 new risk loci and highlight key pathways and regulatory variants

Nature Genetics

Volumn 48, Issue 11, 2016, Pages 1418-1424

  Jin, Ying ^a,b   Andersen, Genevieve ^a   Yorgov, Daniel ^c   Ferrara, Tracey M ^a   Ben, Songtao ^a   Brownson, Kelly M ^a   Holland, Paulene J ^a   Birlea, Stanca A ^a   Siebert, Janet ^d   Hartmann, Anke ^e   Lienert, Anne ^e   Van Geel, Nanja ^f   Lambert, Jo ^f   Luiten, Rosalie M ^g   Wolkerstorfer, Albert ^g   Wietze Van Der Veen, J P ^g,h   Bennett, Dorothy C ⁱ   Taïeb, Alain ^j   Ezzedine, Khaled ^j   Kemp, E Helen ^k   Gawkrodger, David J ^k   Weetman, Anthony P ^k   Kõks, Sulev ^l   Prans, Ele ^l   Kingo, Külli ^l   Karelson, Maire ^l   Wallace, Margaret R ^m   McCormack, Wayne T ^m   Overbeck, Andreas ⁿ   Moretti, Silvia ^o   Colucci, Roberta ^o   Picardo, Mauro ^p   Silverberg, Nanette B ^q,r   Olsson, Mats ^s   Valle, Yan ^t   Korobko, Igor ^t,u   Böhm, Markus ^v   Lim, Henry W ^w   Hamzavi, Iltefat ^w   Zhou, Li ^w   Mi, Qing Sheng ^w   Fain, Pamela R ^a,b   Santorico, Stephanie A ^a,c,x   Spritz, Richard A ^a,b   more..

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b University of Colorado Denver and Children s Hospital Colorado   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d CytoAnalytics   (United States)

^e UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^f GHENT UNIVERSITY HOSPITAL   (Belgium)

^g UNIVERSITY OF AMSTERDAM   (Netherlands)

^h MEDICAL CENTER HAAGLANDEN   (Netherlands)

ⁱ ST GEORGE S HOSPITAL   (United Kingdom)

^j HÔPITAL SAINT ANDRÉ   (France)

^k UNIVERSITY OF SHEFFIELD   (United Kingdom)

^l UNIVERSITY OF TARTU   (Estonia)

^m UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

ⁿ Lumiderm   (Spain)

^o UNIVERSITY OF FLORENCE   (Italy)

^p SAN GALLICANO DERMATOLOGICAL INSTITUTE   (Italy)

^q St Luke's Roosevelt Hospital Center ^*  (United States)

^r ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

^s International Vitiligo Center   (Sweden)

^t Vitiligo Research Foundation   (United States)

^u INSTITUTE OF GENE BIOLOGY   (Russian Federation)

^v UNIVERSITY OF MÜNSTER   (Germany)

^w HENRY FORD HOSPITAL   (United States)

^x Food Science and Human Nutrition   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 22; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1BETA; STAT4 PROTEIN;

ANCESTRY GROUP; ARTICLE; AUTOIMMUNE DISEASE; AUTOSOME; BIOINFORMATICS; CONTROLLED STUDY; EUROPEAN; GENE; GENE EXPRESSION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOME-WIDE ASSOCIATION STUDY; HUMAN; IFIH1 GENE; IL2RA GENE; LPP GENE; MAJOR HISTOCOMPATIBILITY COMPLEX; MC1R GENE; MELANOCYTE; PRIORITY JOURNAL; QUANTITATIVE TRAIT LOCUS; SLA TG GENE; TYR GENE; UBASH3A GENE; VITILIGO; FEMALE; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; MALE; MELANOMA; META ANALYSIS; RISK ASSESSMENT;

AUTOIMMUNE DISEASES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; MALE; MELANOMA; QUANTITATIVE TRAIT LOCI; RISK ASSESSMENT; VITILIGO;

EID: 84990955100     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng.3680     Document Type: Article

References (69)

1. Picardo, M. & Taïeb, A. Vitiligo (Springer, 2010).
2. Alkhateeb, A., Fain, P.R., Thody, A., Bennett, D.C. & Spritz, R.A. Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families. Pigment Cell Res. 16, 208-214 (2003).
3. Jin, Y. et al. NALP1 in vitiligo-associated multiple autoimmune disease. N. Engl. J. Med. 356, 1216-1225 (2007).
4. Jin, Y. et al. Variant of TYR and autoimmunity susceptibility loci in generalized vitiligo. N. Engl. J. Med. 362, 1686-1697 (2010).
5. Jin, Y. et al. Common variants in FOXP1 are associated with generalized vitiligo. Nat. Genet. 42, 576-578 (2010).
6. Jin, Y. et al. Genome-wide association analyses identify 13 new susceptibility loci for generalized vitiligo. Nat. Genet. 44, 676-680 (2012).
7. Ricaño-Ponce, I. & Wijmenga, C. Mapping of immune-mediated disease genes. Annu. Rev. Genomics Hum. Genet. 14, 325-353 (2013).
8. Liu, F. et al. Genetics of skin color variation in Europeans: genome-wide association studies with functional follow-up. Hum. Genet. 134, 823-835 (2015).
9. Reimand, J., Arak, T. & Vilo, J. g:Profler-a web server for functional interpretation of gene lists (2011 update). Nucleic Acids Res. 39, W307-W315 (2011).
10. Mi, H., Poudel, S., Muruganujan, A., Casagrande, J.T. & Thomas, P.D. PANTHER version 10: expanded protein families and functions, and analysis tools. Nucleic Acids Res. 44, D336-D342 (2016).
11. Szklarczyk, D. et al. STRING v10: protein-protein interaction networks, integrated over the tree of life. Nucleic Acids Res. 43, D447-D452 (2015).
12. Wilbe, M. et al. Multiple changes of gene expression and function reveal genomic and phenotypic complexity in SLE-like disease. PLoS Genet. 11, e1005248 (2015).
13. Wang, X., Xing, D., Liu, L. & Chen, W.R. BimL directly neutralizes Bcl-xL to promote Bax activation during UV-induced apoptosis. FEBS Lett. 583, 1873-1879 (2009).
14. Linsley, P.S. et al. Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors. Immunity 1, 793-801 (1994).
15. Stegh, A.H. et al. Bcl2L12 inhibits post-mitochondrial apoptosis signaling in glioblastoma. Genes Dev. 21, 98-111 (2007).
16. Sun, J. et al. A cytosolic granzyme B inhibitor related to the viral apoptotic regulator cytokine response modifer A is present in cytotoxic lymphocytes. J. Biol. Chem. 271, 27802-27809 (1996).
17. + regulatory T cells. Science 325, 1142-1146 (2009).
18. Akiyama, T., Shinzawa, M. & Akiyama, N. RANKL-RANK interaction in immune regulatory systems. World J. Orthop. 3, 142-150 (2012).
19. Ollmann, M.M., Lamoreux, M.L., Wilson, B.D. & Barsh, G.S. Interaction of Agouti protein with the melanocortin 1 receptor in vitro and in vivo. Genes Dev. 12, 316-330 (1998).
20. Praetorius, C. et al. A polymorphism in IRF4 affects human pigmentation through a tyrosinase-dependent MITF/TFAP2A pathway. Cell 155, 1022-1033 (2013).
21. Jin, Y. et al. Next-generation DNA re-sequencing identifes common variants of TYR and HLA-A that modulate the risk of generalized vitiligo via antigen presentation. J. Invest. Dermatol. 132, 1730-1733 (2012).
22. Gualco, G., Weiss, L.M. & Bacchi, C.E. MUM1/IRF4: a review. Appl. Immunohistochem. Mol. Morphol. 18, 301-310 (2010).
23. Visser, M., Palstra, R.J. & Kayser, M. Allele-specifc transcriptional regulation of IRF4 in melanocytes is mediated by chromatin looping of the intronic rs12203592 enhancer to the IRF4 promoter. Hum. Mol. Genet. 24, 2649-2661 (2015).
24. Nan, H. et al. Genome-wide association study of tanning phenotype in a population of European ancestry. J. Invest. Dermatol. 129, 2250-2257 (2009).
25. Shoag, J. et al. PGC-1 coactivators regulate MITF and the tanning response. Mol. Cell 49, 145-157 (2013).
26. Read, J., Wadt, K.A. & Hayward, N.K. Melanoma genetics. J. Med. Genet. 53, 1-14 (2016).
27. Spritz, R.A. The genetics of generalized vitiligo: autoimmune pathways and an inverse relationship with malignant melanoma. Genome Med. 2, 78 (2010).
28. Das, P.K., van den Wijngaard, R.M.J.G.J., Wankowicz-Kalinska, A. & Le Poole, I.C. A symbiotic concept of autoimmunity and tumour immunity: lessons from vitiligo. Trends Immunol. 22, 130-136 (2001).
29. Teulings, H.E. et al. Decreased risk of melanoma and nonmelanoma skin cancer in patients with vitiligo: a survey among 1307 patients and their partners. Br. J. Dermatol. 168, 162-171 (2013).
30. Paradisi, A. et al. Markedly reduced incidence of melanoma and nonmelanoma skin cancer in a nonconcurrent cohort of 10,040 patients with vitiligo. J. Am. Acad. Dermatol. 71, 1110-1116 (2014).
31. Teulings, H.E. et al. Vitiligo-like depigmentation in patients with stage III-IV melanoma receiving immunotherapy and its association with survival: a systematic review and meta-analysis. J. Clin. Oncol. 33, 773-781 (2015).
32. Laberge, G. et al. Early disease onset and increased risk of other autoimmune diseases in familial generalized vitiligo. Pigment Cell Res. 18, 300-305 (2005).
33. Dubois, P.C. et al. Multiple common variants for celiac disease infuencing immune gene expression. Nat. Genet. 42, 295-302 (2010).
34. Franke, A. et al. Genome-wide meta-analysis increases to 71 the number of confrmed Crohn's disease susceptibility loci. Nat. Genet. 42, 1118-1125 (2010).
35. Juyal, G. et al. Genome-wide association scan in north Indians reveals three novel HLA-independent risk loci for ulcerative colitis. Gut 64, 571-579 (2015).
36. Melum, E. et al. Genome-wide association analysis in primary sclerosing cholangitis identifes two non-HLA susceptibility loci. Nat. Genet. 43, 17-19 (2011).
37. Petukhova, L. et al. Genome-wide association study in alopecia areata implicates both innate and adaptive immunity. Nature 466, 113-117 (2010).
38. Gregersen, P.K. et al. REL, encoding a member of the NF-κB family of transcription factors, is a newly defned risk locus for rheumatoid arthritis. Nat. Genet. 41, 820-823 (2009).
39. Chu, X. et al. A genome-wide association study identifes two new risk loci for Graves' disease. Nat. Genet. 43, 897-901 (2011).
40. Eriksson, N. et al. Novel associations for hypothyroidism include known autoimmune risk loci. PLoS One 7, e34442 (2012).
41. Renton, A.E. et al. A genome-wide association study of myasthenia gravis. JAMA Neurol. 72, 396-404 (2015).
42. Plagnol, V. et al. Genome-wide association analysis of autoantibody positivity in type 1 diabetes cases. PLoS Genet. 7, e1002216 (2011).
43. Yang, W. et al. Meta-analysis followed by replication identifes loci in or near CDKN1B, TET3, CD80, DRAM1, and ARID5B as associated with systemic lupus erythematosus in Asians. Am. J. Hum. Genet. 92, 41-51 (2013).
44. Hou, S. et al. Identifcation of a susceptibility locus in STAT4 for Behçet's disease in Han Chinese in a genome-wide association study. Arthritis Rheum. 64, 4104-4113 (2012).
45. Li, Y. et al. A genome-wide association study in Han Chinese identifes a susceptibility locus for primary Sjögren's syndrome at 7q11.23. Nat. Genet. 45, 1361-1365 (2013).
46. Lee, Y.H., Bae, S.C., Choi, S.J., Ji, J.D. & Song, G.G. Genome-wide pathway analysis of genome-wide association studies on systemic lupus erythematosus and rheumatoid arthritis. Mol. Biol. Rep. 39, 10627-10635 (2012).
47. Han, J.W. et al. Genome-wide association study in a Chinese Han population identifes nine new susceptibility loci for systemic lupus erythematosus. Nat. Genet. 41, 1234-1237 (2009).
48. Corradin, O. & Scacheri, P.C. Enhancer variants: evaluating functions in common disease. Genome Med. 6, 85 (2014).
49. Gusev, A. et al. Partitioning heritability of regulatory and cell-type-specifc variants across 11 common diseases. Am. J. Hum. Genet. 95, 535-552 (2014).
50. Paul, D.S., Soranzo, N. & Beck, S. Functional interpretation of non-coding sequence variation: concepts and challenges. BioEssays 36, 191-199 (2014).
51. Finucane, H.K. et al. Partitioning heritability by functional annotation using genome-wide association summary statistics. Nat. Genet. 47, 1228-1235 (2015).
52. Nicolae, D.L. et al. Trait-associated SNPs are more likely to be eQTLs: annotation to enhance discovery from GWAS. PLoS Genet. 6, e1000888 (2010).
53. Ferrara, T.M., Jin, Y., Gowan, K., Fain, P.R. & Spritz, R.A. Risk of generalized vitiligo is associated with the common 55R-94A-247H variant haplotype of GZMB (encoding granzyme B). J. Invest. Dermatol. 133, 1677-1679 (2013).
54. Hayashi, M. et al. Autoimmune vitiligo is associated with gain-of-function by a transcriptional regulator that elevates expression of HLA-A∗02:01 in vivo. Proc. Natl. Acad. Sci. USA 113, 1357-1362 (2016).
55. Cavalli, G. et al. MHC class II super-enhancer increases surface expression of HLA-DR and HLA-DQ and affects cytokine production in autoimmune vitiligo. Proc. Natl. Acad. Sci. USA 113, 1363-1368 (2016).
56. Shlyueva, D., Stampfel, G. & Stark, A. Transcriptional enhancers: from properties to genome-wide predictions. Nat. Rev. Genet. 15, 272-286 (2014).
57. Kellis, M. et al. Defning functional DNA elements in the human genome. Proc. Natl. Acad. Sci. USA 111, 6131-6138 (2014).
58. Gamazon, E.R. et al. A gene-based association method for mapping traits using reference transcriptome data. Nat. Genet. 47, 1091-1098 (2015).
59. Taïeb, A. & Picardo, M. The defnition and assessment of vitiligo: a consensus report of the Vitiligo European Task Force. Pigment Cell Res. 20, 27-35 (2007).
60. Purcell, S. et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 81, 559-575 (2007).
61. Price, A.L. et al. Principal components analysis corrects for stratifcation in genome-wide association studies. Nat. Genet. 38, 904-909 (2006).
62. Chang, D. et al. Accounting for eXentricities: analysis of the X chromosome in GWAS reveals X-linked genes implicated in autoimmune diseases. PLoS One 9, e113684 (2014).
63. Higgins, J.P. & Thompson, S.G. Quantifying heterogeneity in a meta-analysis. Stat. Med. 21, 1539-1558 (2002).
64. Higgins, J.P., Thompson, S.G., Deeks, J.J. & Altman, D.G. Measuring inconsistency in meta-analyses. Br. Med. J. 327, 557-560 (2003).
65. Lee, A.B., Luca, D., Klei, L., Devlin, B. & Roeder, K. Discovering genetic ancestry using spectral graph theory. Genet. Epidemiol. 34, 51-59 (2010).
66. Fairfax, B.P. et al. Innate immune activity conditions the effect of regulatory variants upon monocyte gene expression. Science 343, 1246949 (2014).
67. Giambartolomei, C. et al. Bayesian test for colocalisation between pairs of genetic association studies using summary statistics. PLoS Genet. 10, e1004383 (2014).
68. Guo, H. et al. Integration of disease association and eQTL data using a Bayesian colocalisation approach highlights six candidate causal genes in immune-mediated diseases. Hum. Mol. Genet. 24, 3305-3313 (2015).
69. Arloth, J., Bader, D.M., Röh, S. & Altmann, A. Re-Annotator: annotation pipeline for microarray probe sequences. PLoS One 10, e0139516 (2015).